OXFYY (Oxford Nanopore Technologies) Receivables Turnover: 2.11 (As of Dec. 2025)


OXFYY Oxford Nanopore Technologies PLC OXFYY
50 GF Score
Price $6.50
GF Value $10.38
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Oxford Nanopore Technologies Receivables Turnover?

Oxford Nanopore Technologies OXFYY -11.92% 50 Receivables Turnover is 2.11 as of Dec. 2025. GuruFocus rates OXFYY with a GF Score™ of 50/100 and a GF Value™ of $10.38 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 839 Biotechnology companies, Oxford Nanopore Technologies ranks worse than 57.81% on this metric.

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Oxford Nanopore Technologies's Revenue for the six months ended in Dec. 2025 was $158.4 Mil. Oxford Nanopore Technologies's average Accounts Receivable for the six months ended in Dec. 2025 was $75.1 Mil. Hence, Oxford Nanopore Technologies's Receivables Turnover for the six months ended in Dec. 2025 was 2.11.


Oxford Nanopore Technologies  (OTCPK:OXFYY) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Oxford Nanopore Technologies Receivables Turnover Related Terms


Oxford Nanopore Technologies Receivables Turnover Historical Data

* Premium members only.

The historical data trend for Oxford Nanopore Technologies's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford Nanopore Technologies Receivables Turnover Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Receivables Turnover
Get a 7-Day Free Trial 3.05 4.98 4.83 5.16 5.48

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.87 1.78 2.01 2.12 2.11

OXFYY vs VRTX, REGN, ALNY: Receivables Turnover Comparison

For the Biotechnology subindustry, Oxford Nanopore Technologies's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Nanopore Technologies Receivables Turnover vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Oxford Nanopore Technologies's Receivables Turnover falls into.


OXFYY
50GF Score
Oxford Nanopore Technologies PLC OXFYY
Receivables Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oxford Nanopore Technologies Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Oxford Nanopore Technologies's Receivables Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Receivables Turnover (A: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (A: Dec. 2025 ) / ((Accounts Receivable (A: Dec. 2024 ) + Accounts Receivable (A: Dec. 2025 )) / count )
=299.732 / ((47.155 + 62.249) / 2 )
=299.732 / 54.702
=5.48

Oxford Nanopore Technologies's Receivables Turnover for the quarter that ended in Dec. 2025 is calculated as

Receivables Turnover (Q: Dec. 2025 )
=Revenue / Average Accounts Receivable
=Revenue (Q: Dec. 2025 ) / ((Accounts Receivable (Q: Jun. 2025 ) + Accounts Receivable (Q: Dec. 2025 )) / count )
=158.367 / ((87.924 + 62.249) / 2 )
=158.367 / 75.0865
=2.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Receivables Turnover →
What does a Receivables Turnover of 2.11 mean?
Oxford Nanopore Technologies (OXFYY) has a Receivables Turnover of 2.11 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Oxford Nanopore Technologies and its competitors. According to the industry distribution chart, Oxford Nanopore Technologies ranks #485 out of 839 companies in the Biotechnology industry, placing it in the top 57.8%.
Is Oxford Nanopore Technologies' Receivables Turnover too high?
Oxford Nanopore Technologies' current Receivables Turnover is 2.11. The Biotechnology industry median Receivables Turnover is 5.29. Oxford Nanopore Technologies' value of 2.11 is 60.1% below this industry median. Based on the distribution chart, Oxford Nanopore Technologies ranks #485 out of 839 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Oxford Nanopore Technologies has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oxford Nanopore Technologies' Receivables Turnover compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxford Nanopore Technologies ranks #485 out of 839 companies for Receivables Turnover. This places Oxford Nanopore Technologies in the lower half of its industry. The industry median Receivables Turnover is 5.29. Oxford Nanopore Technologies' value of 2.11 is 60.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.29, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oxford Nanopore Technologies's current Receivables Turnover of 2.11 is 60.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Oxford Nanopore Technologies and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford Nanopore Technologies's current Receivables Turnover is 2.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford Nanopore Technologies stock overvalued right now?
Based on GuruFocus' analysis, Oxford Nanopore Technologies (OXFYY) is currently considered Significantly Undervalued. The stock's GF Value™ is $10.38, compared to a current price of $6.50 — trading 37.4% below its estimated fair value. The current Receivables Turnover is 2.11 and 60.1% below the Biotechnology industry median of 5.29. Oxford Nanopore Technologies' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Oxford Nanopore Technologies (OXFYY), the current Receivables Turnover is 2.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oxford Nanopore Technologies (OXFYY) Overvalued in 2026?

Based on GuruFocus' analysis, Oxford Nanopore Technologies stock appears to be undervalued. The current stock price of $6.50 is trading 37.4% below its estimated GF Value™ of $10.38. GuruFocus considers Oxford Nanopore Technologies to be Significantly Undervalued.

Key valuation signals for OXFYY:

  • Receivables Turnover: 2.11
  • GF Value™: $10.38 vs. price of $6.50 (37.4% below fair value)
  • GF Score™: 50/100 with 2 warning signs
  • Industry Position: 60.1% below the Biotechnology median (#485 of 839)

No single metric tells the full story. See the OXFYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oxford Nanopore Technologies Business Description

Address Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
50GF Score

Get the complete analysis for OXFYY

Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.50
Price
$10.38
GF Value